Anteris

Anteris Technologies Ltd is a public medical device company (ASX: AVR) focused on designing, developing, and commercializing innovative solutions for structural heart disease. The company's flagship product is the DurAVR™ 3D single-piece aortic valve replacement, which is engineered to be more durable and provide better hemodynamics compared to current-generation valves. Formerly known as Admedus, the company rebranded to Anteris to reflect its primary focus on this novel heart valve technology, with a mission to improve the lives of patients suffering from aortic stenosis.